Sign up to save your podcasts
Or
Share ARREST: Rifampicin for Staph. aureus bacteraemia (short version)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ARREST: Rifampicin for Staph. aureus bacteraemia (short version)
Staphylococcus aureus (S. aureus) bacteraemia is a common infection worldwide, with mortality rates of around 20%, but little research has been done on how best to treat it. This episode explores the results of the ARREST trial, which looked at adding rifampicin to standard antistaphylococcal antibiotic treatment. This is the short version of the recording. A longer version is available on the MRC CTU SoundCloud.
View all episodes
By MRC Clinical Trials Unit at UCLStaphylococcus aureus (S. aureus) bacteraemia is a common infection worldwide, with mortality rates of around 20%, but little research has been done on how best to treat it. This episode explores the results of the ARREST trial, which looked at adding rifampicin to standard antistaphylococcal antibiotic treatment. This is the short version of the recording. A longer version is available on the MRC CTU SoundCloud.